You can buy or sell APRE and other stocks, options, ETFs, and crypto commission-free!
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Read More The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA. The listed name for APRE is Aprea Therapeutics, Inc. Common stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, After Hours